Gustavo G Fernandez-Ranvier, MD, PhD
- ASSOCIATE PROFESSOR | Metabolic, Endocrine and Minimally Invasive Surgery
Specialties:Surgery, Bariatric Surgery
Research Topics:Anti-Tumor Therapy, Apoptosis/Cell Death, Cancer Genetics, Diabetes, Obesity, Thyroid, Tumor Suppressor Genes, Tumorigenesis
Dr. Fernandez-Ranvier is a board certified and fellowship trained surgeon who received his Bachelor’s degree in biology and his Doctor of Medicine at the University of Buenos Aires School of Medicine in Argentina. Dr. Fernandez-Ranvier has undergone extensive training. He completed his residency in general surgery at A. Posadas /Parmenio Piniero Hospital in Buenos Aires, Argentina. Thereafter, he attended the University of California, where he completed a three year postdoctoral fellowship in Endocrine Surgical Oncology and a clinical fellowship in Colorectal Surgery focusing on minimally invasive approaches and robotic surgery for the treatment of colon and rectal cancer. Dr. Fernandez-Ranvier remained in California, where he completed additional residency programs at Loma Linda University Medical Center and San Joaquin General Hospital. He has also obtained a Doctor of Philosophy degree (PhD) at the University of Buenos Aires – School of Medicine with his PhD thesis entitled “Clinical and Molecular Pathogenesis of Parathyroid Tumors”. This original research was performed at the University of California at San Francisco during his postdoctoral fellowship under the mentorship of world renowned endocrine surgeon, Dr Orlo H. Clark. Dr. Fernandez-Ranvier completed his fellowship in Minimally Invasive Endocrine and Metabolic Surgery at the Icahn School of Medicine at Mount Sinai and is currently an Assistant Professor in Surgery at the Mount Sinai Hospital in New York. His areas of specialty and research interests include thyroid and parathyroid disease, adrenal and pancreatic neuroendocrine tumors, and minimally invasive and bariatric surgery.
American Board of Surgery
- Abdominal Hernia
- Abdominal Surgery
- Adrenal Cortical Carcinoma
- Adrenal Gland Tumors
- Adrenalectomy-Laparoscopic Surgery
- Adrenalectomy-Open Surgery
- Antireflux Surgery
- Bariatric Surgery
- Breast Biopsy
- Breast Surgery
- Bypass Surgery Consultation - CABG
- Cholecystectomy-Laparoscopic Surgery
- Colectomy-Laparoscopic Surgery
- Colorectal Surgery
- Endocrine Pancreas Tumors
- Endocrine Tumors
- Endovenous Laser Treatment of Varicose Veins
- Fundoplication-Laparoscopic Surgery
- Gastroesophageal Reflux Disease
- Gender Confirmation Surgery
- Laparoscopic Hernia Repair
- Laparoscopic Intestinal Surgery
- Lysis Of Adhesions
- Metabolic Syndrome
- Parathyroid Neoplasia
- Pelvic Surgery
- Pheochromocytomas And Paragangliomas
- Sleeve Gastrectomy
- Small Bowel Resection
- Surgery Second Opinion
- Thyroid Cancer
- Thyroid Nodule
- Weight Loss Consultation
MD, Universidad de Buenos Aires
MD, University of Buenos Aires – School of Medicine
Residency, Surgery (General Surgery), Hospital Posadas
Residency, Surgery (General Surgery), Loma Linda University Hospital Medical Center
Residency, Surgery (General Surgery), San Joaquin General Hospital
Fellowship, Surgery (General Surgery), University of California San Francisco
Areas of Interest
Areas of research interests include thyroid and parathyroid disease, adrenal and pancreatic neuroendocrine tumors, and minimally invasive and bariatric procedures. The summer of 2015, he defended his PhD thesis entitled “Molecular Pathogenesis of Parathyroid Tumors.” This original research was performed at the University of California at San Francisco during his postdoctoral fellowship, under the mentorship of world-renowned endocrine surgeon, Dr. Orlo H. Clark.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Fernandez-Ranvier did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.